Hana Ju

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Clinical Practice

Positron Emission Tomography

Chronic Lymphocytic Leukemia

Top Venues

Expert opinion on biological therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Min-Ho Park, Jae Hong Seo, Jung Ho Park, Min-Ki Seong, Keon Uk Park, Min Kyoon Kim, Myung Chul Chang, Su Jin Koh, Moon Hee Lee, Seung Taek Lim, Young-Bum Yoo, So Yeon Oh, Sung Hyun Kim, Keum Young Ahn, Tae Hong Park, Hana Ju, Eric Hyungseok Baek, Sinhye Kim, Nahyun Kim, Eunkyung Lee, Tae Hyun Kim
Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study. Expert opinion on biological therapy 24 (4) (2024)
Min-Ho Park, Jae Hong Seo, Jung Ho Park, Min-Ki Seong, Keon Uk Park, Min Kyoon Kim, Myung Chul Chang, Su Jin Koh, Moon Hee Lee, Seung Taek Lim, Young-Bum Yoo, So Yeon Oh, Sung Hyun Kim, Keum Young Ahn, Tae Hong Park, Hana Ju, Eric Hyungseok Baek, Sinhye Kim, Nahyun Kim, Eunkyung Lee, Tae Hyun Kim
Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study. Expert opinion on biological therapy 24 (4) (2024)
Min-Ho Park, Jae Hong Seo, Jung Ho Park, Min-Ki Seong, Keon Uk Park, Min Kyoon Kim, Myung Chul Chang, Su Jin Koh, Moon Hee Lee, Seung Taek Lim, Young-Bum Yoo, So Yeon Oh, Sung Hyun Kim, Keum Young Ahn, Tae Hong Park, Hana Ju, Eric Hyungseok Baek, Sinhye Kim, Nahyun Kim, Eunkyung Lee, Tae Hyun Kim
Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study. Expert opinion on biological therapy 24 (4) (2024)
Min-Ho Park, Jae Hong Seo, Jung Ho Park, Min-Ki Seong, Keon Uk Park, Min Kyoon Kim, Myung Chul Chang, Su Jin Koh, Moon Hee Lee, Seung Taek Lim, Young-Bum Yoo, So Yeon Oh, Sung Hyun Kim, Keum Young Ahn, Tae Hong Park, Hana Ju, Eric Hyungseok Baek, Sinhye Kim, Nahyun Kim, Eunkyung Lee, Tae Hyun Kim
Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study. Expert opinion on biological therapy (2024)
Jae-Cheol Jo, Young-Woo Jeon, Da Jung Kim, Deok-Hwan Yang, Won Sik Lee, Yoon Seok Choi, Jun Ho Yi, Dok Hyun Yoon, Jee Hyun Kong, Jung-Yoon Choe, SungHyun Kim, Keum Young Ahn, Tae Hong Park, Hana Ju, Soonbum Kwon, Seok-Goo Cho
A non-interventional, post-marketing surveillance study evaluating the safety and effectiveness of biosimilar rituximab (CT-P10) during routine clinical practice in the Republic of Korea. Expert opinion on biological therapy (2023)